Pegasta Injection

Name: Pegasta Injection
Brand: SIDMEX INOVIA PRIVATE LIMITED
Price: 3628.0 INR
Availability: InStock

Price 3628.0 INR/ Pack

Get a Price/Quote

MOQ : 60 Packs, Pack

Pegasta Injection Specification

Drug Type
Injection

Physical Form
Liquid

Function
Anti-Bacterial

Recommended For
Doctor

Dosage Guidelines
As per Instructions

Suitable For
Adults

Storage Instructions
Cool & Dry Place

Pegasta Injection Trade Information

Minimum Order Quantity
60 Packs, Pack

Payment Terms
Cash Advance (CA), Cash in Advance (CID), Telegraphic Transfer (T/T)

Supply Ability
1000 Packs, Pack Per Week

Delivery Time
4 Days

Sample Available
No

Sample Policy
If order is confirmed we will reimburse the sample cost

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Main Domestic Market
All India

About Pegasta Injection

1. Technical Specifications:

Attribute	Details
Brand	Pegasta 6mg Injection
Manufactured By	Intas Pharmaceuticals Ltd., India
Packaging Size	6mg pegfilgrastim in 0.6mL prefilled syringe or liquid vial
Packaging Type	Single-use syringe or vial in carton
Dosage Form	Injectable solution (subcutaneous)
Storage Conditions	Refrigerate at 28C; do not freeze; protect from light
Shelf Life	Typically 2436 months (check batch expiry)
Regulatory Compliance	Manufactured in GMPcertified facility by Intas Pharmaceuticals Ltd.

2. Product Description

Pegasta Injection contains Pegfilgrastim, a long-acting PEGylated recombinant human G-CSF. It stimulates the bone marrow to increase neutrophil production and is used to reduce infection risk (febrile neutropenia) in patients undergoing myelosuppressive chemotherapy. Typically given as a single subcutaneous injection per chemotherapy cycle, about 24hours post-chemotherapy.

3. Product Highlights

Attribute	Details
Generic Name	Pegfilgrastim
Strength	6mg (in 0.6mL volume)
Dosage Form	Ready-to-use liquid (subcutaneous injection)
Therapeutic Category	Hematopoietic growth factor / Colony Stimulating Factor
Application Area	Prevention of chemotherapy-induced neutropenia
Formulation	Sterile solution in prefilled syringe or vial
Storage Conditions	28C refrigerated; avoid freezing and light exposure
Shelf Life	Typically 2436 months
Regulatory Compliance	Produced in GMPcertified facility by Intas Pharmaceuticals

4. Therapeutic Uses

Prevention of febrile neutropenia in non-myeloid malignancy patients receiving chemotherapy.
May also be used in acute radiation syndrome for hematopoietic recovery.

5. Safety Profile & Side Effects

Common side effects:

Bone or musculoskeletal pain
Headache, nausea, fatigue
Injection-site discomfort; occasional flushing, rash, or swelling

Rare but serious risks:

Splenic rupture
Acute respiratory distress syndrome
Leukocytosis (elevated white blood cell count)
Allergic reactions & capillary leak syndrome

6. Precautions

Administer only after approval by healthcare provider and usually 24 hours after chemotherapy.
Monitor CBC regularly to track neutrophil count and avoid overshoots.
May cause dizziness or concentration issuesadvise caution when driving.
Not recommended in pregnancy or while breastfeeding without medical supervision.
Avoid interactions with certain chemotherapeutics (e.g., capecitabine, bendamustine) within 14 days.

Targeted Anti-Bacterial Action

Pegasta Injection delivers rapid and targeted anti-bacterial benefits for adults, helping to treat and control infections effectively. Its liquid form allows for efficient absorption when administered by a medical professional.

Professional Handling Required

This medication is recommended strictly for administration by doctors or trained healthcare providers, ensuring precise dosing and monitoring. It is available to medical distributors, exporters, suppliers, traders, and wholesalers across India.

Storage and Handling Precautions

Pegasta Injection must be stored in a cool and dry place to preserve its quality and efficacy. Careful storage helps prevent degradation of the anti-bacterial components, ensuring optimal therapeutic effect upon use.

FAQs of Pegasta Injection:

Q: How should Pegasta Injection be administered?

A: Pegasta Injection must be given by a qualified healthcare provider such as a doctor, following the recommended dosage and administration technique provided by medical guidelines.

Q: What benefit does Pegasta Injection offer?

A: This injection provides strong anti-bacterial action, aiding in the treatment and management of bacterial infections in adults, resulting in improved health outcomes when used as directed.

Q: When is Pegasta Injection recommended?

A: Pegasta Injection is recommended when a doctor diagnoses a bacterial infection that requires injectable antibiotic therapy for adults. The exact timing and frequency are determined by a healthcare professional.

Q: Where should Pegasta Injection be stored?

A: Pegasta Injection should be kept in a cool and dry place, away from direct sunlight, heat sources, and moisture to ensure its effectiveness and shelf life.

Q: What is the proper usage of Pegasta Injection?

A: The injection should only be used as per instructions from a doctor. Self-administration is not advised; always seek medical supervision to ensure accurate dosing and minimize side effects.